Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Objective To evaluate the effect of the oral synthetic δ-9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic, University Hospital of Aarhus, Denmark. Participan...

ver descrição completa

Detalhes bibliográficos

Publicado no:	BMJ
Principais autores:	Svendsen, Kristina B, Jensen, Troels S, Bach, Flemming W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2004
Assuntos:	Papers
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC498019/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15258006/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38149.566979.AE
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!